Cargando…
Abbreviated lipid guidelines for clinical practice: Based on ESC lipid guidelines 2019 and ESC cardiovascular disease prevention in clinical practice guidelines 2021
BACKGROUND: Lipid disorders are now considered causal for atherosclerotic cardiovascular disease (ASCVD) which remains one of the most important contributors to morbidity and mortality in the developed world. Identification and early treatment of lipid disarrays remains the cornerstone of good clini...
Autores principales: | Maher, Vincent, Gallagher, Joe, Agar, Ruth, Griffin, Damian, Colwell, Niall, O’Connor, Patricia, McAdam, Brendan, Tomkin, Gerald, Owens, Daphne, Ryan, Mary, Tormey, William, Durkan, Maeve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522729/ https://www.ncbi.nlm.nih.gov/pubmed/36746882 http://dx.doi.org/10.1007/s11845-023-03277-x |
Ejemplares similares
-
The Potential Impact of the 2022 ESC Cardio-Oncology Guidelines on Clinical Practice in China
por: Tse, Gary, et al.
Publicado: (2023) -
The ESC Cardio-Oncology Guidelines: A Roadmap for Clinical Practice and Generating Needed Evidence
por: Sparano, Joseph A., et al.
Publicado: (2022) -
The DA VINCI study: is Ireland achieving ESC/EAS guideline–directed LDL-C goals?
por: Offiah, Gregory, et al.
Publicado: (2022) -
From guideline to daily practice: Implementation of ESC-guidelines considering multidisciplinary and non-pharmacological care in heart failure in three ESC member states, a case study
por: Baldewijns, Karolien, et al.
Publicado: (2022) -
Comparison of ESC and ACC/AHA guidelines for myocardial revascularization
por: Stirrup, Jim, et al.
Publicado: (2017)